AS

Ajeesh Sudevan Baby Sarojam

Active Director Director DIN 09406379
DIN 09406379 First appointment Nov 2021 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajeesh Sudevan Baby Sarojam

Data last updated:

Ajeesh Sudevan Baby Sarojam is a Director at Niraamaya Medipro India Private Limited (since 2021). The company operates in Electrnoics.

DIN 09406379
Primary Designation Director
Industry Electrnoics
First Appointment 30 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Nov 20212021Active

Board colleagues of Ajeesh Sudevan Baby Sarojam

NameDINCompanyDesignation
Vishnu Gopinath09406500Niraamaya Medipro India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Niraamaya Medipro India Private Limited
Premium access

Shareholding and investment profile for Ajeesh Sudevan Baby Sarojam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajeesh Sudevan Baby Sarojam

Ajeesh Sudevan Baby Sarojam currently holds 1 directorship: Niraamaya Medipro India Private Limited (Director, since 30 Nov 2021).

Ajeesh Sudevan Baby Sarojam was first appointed on 30 Nov 2021 as Director at Niraamaya Medipro India Private Limited.

The current boards of Ajeesh Sudevan Baby Sarojam's companies include Vishnu Gopinath (Niraamaya Medipro India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available